Anbio Biotechnology Cl A (NNNN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NNNN | AZN | AMGN | GILD | VRTX |
| Company | Anbio Biotechnology Cl A | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 22.17 | 190.33 | 368.27 | 143.50 | 455.59 |
| High | 22.64 | 193.93 | 374.57 | 145.60 | 459.76 |
| Low | 22.17 | 189.35 | 366.53 | 143.49 | 450.78 |
| Latest | 22.33 | 193.32 | 374.09 | 145.32 | 454.84 |
| Change | -0.56 | -0.90 | +4.56 | +1.39 | -1.85 |
| % Change | -2.45% | -0.46% | +1.23% | +0.97% | -0.41% |
| Volume | 3,697 | 1,213,260 | 1,195,412 | 2,117,482 | 408,545 |
| 20-Day Average Volume | 64,545 | 2,242,504 | 2,612,262 | 7,313,399 | 1,414,983 |
| Previous Close | 22.89 | 194.22 | 369.53 | 143.93 | 456.69 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 24.51 | 202.43 | 375.61 | 149.47 | 474.19 |
| 20-Day Raw Stochastic | 12.67% | 22.69% | 40.54% | 14.32% | 5.86% |
| 20-Day Relative Strength | 44.84 | 46.90 | 55.42 | 52.68 | 44.83 |
| Weighted Alpha | -36.09 | +29.19 | +27.22 | +36.13 | -4.80 |
| Today's Opinion | 88% Sell | 64% Buy | 88% Buy | 88% Buy | 64% Buy |
| Previous Opinion | 88% Sell | 80% Buy | 88% Buy | 88% Buy | 64% Buy |
| Last Month's Opinion | 56% Sell | 100% Buy | 100% Buy | 100% Buy | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -2.75% since 03/02/26 | -5.33% since 03/02/26 | -3.22% since 03/02/26 | -3.45% since 03/02/26 | -6.63% since 03/02/26 |
| Low | 21.21 on 03/06/26 | 189.45 on 03/09/26 | 361.39 on 03/05/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 24.74 on 03/04/26 | 203.29 on 03/04/26 | 381.74 on 03/03/26 | 148.92 on 03/04/26 | 484.10 on 03/03/26 |
| 1-Month | |||||
| %Chg | -4.21% since 02/09/26 | +2.59% since 02/09/26 | -0.68% since 02/09/26 | -4.50% since 02/09/26 | -3.63% since 02/09/26 |
| Low | 21.21 on 03/06/26 | 189.45 on 03/09/26 | 361.00 on 02/11/26 | 142.77 on 03/06/26 | 450.67 on 03/06/26 |
| High | 30.49 on 02/27/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 3-Month | |||||
| %Chg | -33.99% since 12/09/25 | +7.37% since 12/09/25 | +18.94% since 12/09/25 | +21.36% since 12/09/25 | +3.84% since 12/09/25 |
| Low | 18.50 on 01/27/26 | 178.08 on 01/21/26 | 312.39 on 12/11/25 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 44.44 on 01/29/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| 6-Month | |||||
| %Chg | -51.53% since 09/09/25 | +18.74% since 09/09/25 | +33.33% since 09/09/25 | +25.13% since 09/09/25 | +14.45% since 09/09/25 |
| Low | 10.50 on 11/04/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 51.33 on 10/03/25 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 503.88 on 02/13/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,293,665 | 301,217,344 | 199,201,792 | 178,677,728 | 116,014,792 |
| Shares Outstanding, K | 143,891 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 8,190,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | 2,370,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | N/A | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | N/A | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | N/A | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | N/A | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | N/A | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.790 on 12/15/25 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 21.56 | 16.82 | 17.81 | 28.06 |